Discussing on thrombosis and hemorrhage in cancer

The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.

The major topics of the conference are:

  • Epidemiology
  • Thromboprophylaxis in Medical Patients
  • Treatment of VTE
  • Thromboprophylaxis in Surgical Patients
  • Hypercoagulation and Biomarkers
  • Complement-driven Thrombotic Syndromes
  • Gender- and Age-related Issues
  • Hemostasis in Cancer Biology
  • Molecular Mechanisms of Thrombosis in Cancer
  • Tumor Cell/Vascular Cell Interactions
  • Angiogenesis
  • Inflammation
  • New Antithrombotic Drugs
  • Anticoagulation and Cancer Survival
  • Arterial Thrombosis
  • Bleeding
  • Congenital and Acquired Risk Factors
  • Thrombohemorrhagic Syndromes (e.g. DIC, TTP, NBTE, VOD)
  • Thrombocytopenia in cancer
  • Antitumor Properties of Antithrombotics
  • Microparticles
  • New Assays for Hypercoagulability
  • Fibrinolysis
  • Proteases